Cargando…
Rhinosinus Mucormycosis with Drug-induced Pancytopenia in an Immunocompromised Severe COVID-19 Patient: A Success
Secondary infections in coronavirus disease (COVID) are becoming common. We report a case of a female known case of diabetes, sarcoidosis on steroids and methotrexate admitted with COVID pneumonia. She was treated with steroids, remdesivir, and anticoagulants and was discharged. She revisited the ho...
Autores principales: | Mahajan, Anurag, Tandon, Vineeta Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015925/ https://www.ncbi.nlm.nih.gov/pubmed/35519907 http://dx.doi.org/10.5005/jp-journals-10071-24134 |
Ejemplares similares
-
Disseminated Histoplasmosis: A Rare Cause of Pancytopenia in an Immunocompromised Patient
por: Avva, Kalyani, et al.
Publicado: (2022) -
Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19
por: Sharma, Neelam, et al.
Publicado: (2022) -
A Rare Cause of Drug-Induced Pancytopenia: Trimethoprim–Sulfamethoxazole-Induced Pancytopenia
por: Sawalha, Khalid, et al.
Publicado: (2021) -
A Case of Post-COVID-19 Rhino-Cerebral Mucormycosis in an Immunocompromised Patient
por: Faria, Labeeba, et al.
Publicado: (2023) -
Severe Pancytopenia Induced by Valproic Acid
por: Wahba, Andrew, et al.
Publicado: (2020)